Giapreza

Active Ingredient(s): Angiotensin II
FDA Approved: * December 21, 2017
Pharm Company: * LA JOLLA PHARM CO
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Giapreza Overview

4FYS, 1N9U, 1N9V, 2JP8, 2WXW, 2X0B, 3CK0, 3WOO, 3WOR, 4AA1, 4APH, 5E2Q Identifiers Aliases AGT, ANHU, SERPINA8, angiotensinogen, hFLT1 External IDs MGI: 87963 HomoloGene: 14 GeneCards: AGT Gene location (Human) Chr. Chromosome 1 (human)[1] Band 1q42.2 Start 230,702,523 bp[1] End 230,714,297 bp[1] Gene location (Mouse) Chr. Chromosome 8 (mouse)[2] Band 8 E2|8 72.81 cM Start 124,556,534 bp[2] End 124,569,706 bp[2] RNA expre...

Read more Giapreza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Angiotensin

Recent Giapreza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Angiotensin II

Solution: 2.5mg/ml (2.5mg/ml), 5mg/2ml (2.5mg/ml)

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Giapreza: (1 result)

Sorted by National Drug Code

68547-501 Giapreza 2.5 mg/ml Intravenous Injection by La Jolla Pharmaceutical Company

Other drugs which contain Angiotensin II or a similar ingredient: (1 result)

Angiotensin II